The rising prevalence of diabetes entails a greater need for treatment and monitoring. In this context, multiple growth opportunities arise in the continuous glucose monitoring (CGM) solutions market. CGM devices have been extensively used for Type 1 diabetes patients. With further technological development and clinical studies, CGM’s applications expand toward Type 2 diabetes, prediabetes, weight management, nutrition tracking, and metabolic health tracking.
Most Type 1 diabetes patients—the main users of CGM—do not use these solutions due to their high costs and low reimbursements, especially in low- and middle-income countries. The adoption of these devices is very low in Asia-Pacific, Latin America, and the Middle East and Africa due to low accessibility, awareness, and affordability. A vast patient pool of diabetic and prediabetic patients needing treatment in these regions creates attractive opportunities for CGM vendors.
Vendors in the CMG solutions industry are partnering with various players across the diabetes treatment ecosystem to increase CGM adoption, data integration, and device combability. Examples of these partnerships are common between CGM vendors and insulin pen, insulin pump, and diabetes management platform providers. Technological advancements and strategic partnerships create new opportunities for CGM vendors.
Research Highlights:
- Market size by revenue, covering historic and forecast data by segment (Homecare and Other Care Settings) and region (North America, Europe, Asia-Pacific, and the rest of the world)
- Market drivers and restraints
- Competitive landscape, including company market share analysis
- Market opportunity size and new business models
- Technological trends and growth opportunities for stakeholders
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Continuous Glucose Monitoring Solutions Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Segmentation
Global Burden of Diabetes
Diabetes Devices
Key Competitors
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast by End User
Revenue Forecast by Region
Revenue Forecast Analysis
Revenue Forecast Analysis by Region
Pricing Trends and Forecast Analysis
CGM Devices by Components
Competitive Environment
Revenue Share
Revenue Share Analysis
CGM Solutions—Key Vendor Presence by Region
Changes in Regional Share of Diabetes
CGM Solutions—Diabetes by Region
China
India
Saudi Arabia
End Users—CGM
Diabetic Users
Diabetic Users (continued)
Prediabetes
Athletes and Fitness Management
Athletes and Fitness Management (continued)
Wellness—Weight Management
End Users—Summary
New Business Models
New Business Models (continued)
New Business Models (continued)
New Business Models (continued)
Noninvasive Monitoring Technologies
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Opportunity 1: Partnerships with Diabetes and Chronic Disease Solutions Providers
Growth Opportunity 1: Partnerships with Diabetes and Chronic Disease Solutions Providers (continued)
Growth Opportunity 2: Hospitals
Growth Opportunity 2: Hospitals (continued)
Growth Opportunity 3: Wellness and Nondiabetic Applications
Growth Opportunity 3: Wellness and Nondiabetic Applications (continued)
Growth Opportunity 4: Emerging Markets
Growth Opportunity 4: Emerging Markets (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures- CMG Solutions: Total Health Expenditure Due To Diabetes, Global, 2007–2045
- CMG Solutions: Diabetes Prevalence, 20–79 years, Global, 2007–2045
- CGM Solutions: Growth Metrics, Global, 2022
- CGM Solutions: Growth Drivers, Global, 2023–2027
- CGM Solutions: Growth Restraints, Global, 2023–2027
- CGM Solutions: Revenue Forecast, Global, 2020–2027
- CGM Solutions: Revenue Forecast by End User, Global, 2020–2027
- CGM Solutions: Revenue Forecast by Region, 2020–2027
- CGM Solutions: Revenue Share by Component, Global, 2022
- CGM Solutions: Revenue Share of Top Participants, Global, 2022
- CGM Solutions: Key Vendor Presence in CGM by Region, 2023
- CGM Solutions: Changes in Diabetes Prevalence by Region, Global, 2021 and 2045
- CGM Solutions: Target Regions for Diabetes, Global, 2021 and 2045
- CGM Solutions: Top 3 Reasons Hindering CGM Use in Tertiary Hospitals, China, 2021
- CGM Solutions: User Frequency of Use of Diabetic Devices Among Diabetic Patients, Saudi Arabia, 2020–2021
- CGM Solutions: CGM Adoption Challenges, Saudi Arabia, 2020–2021
- CGM Solutions: CGM Satisfaction Level, Saudi Arabia, 2020–2021
- CGM Solutions: Diabetes Prevalence by Type, Global, 2021
- CGM Solutions: Insulin Users, Global, 2021 and 2030
- CGM Solutions: Non-insulin Users, Global, 2021 and 2030
- CGM Solutions: Number of hospital beds, Global, 2020 and 2030
- Diabetes Devices and Services: Prediabetic Population by Region, Global, 2030
- CGM Solutions: Sports Participation, TAM and Opportunity Size, Global, 2030
- CGM Solutions: Athletes, TAM and Opportunity Size, Global, 2030
- CGM Solutions: Number of People Who Are Overweight or Obese (BMI≥25kg/m²), Global, 2020–2030
- Healthy Eating, Nutrition, and Weight Loss: Regional Share, Global, 2020
- Diabetes Devices and Services: Noninvasive Glucose Measurement, Start-ups’ Progress, Global, 2022
- Homecare Settings: Growth Metrics, Global, 2022
- Homecare Settings: Revenue Forecast, Global, 2020–2027
- Homecare Settings: Revenue Forecast by Region, 2020–2027
- Hospitals and Other Care Settings: Growth Metrics, Global, 2022
- Hospitals and Other Care Settings: Revenue Forecast, Global, 2020–2027
- Hospitals and other care settings: Revenue Forecast by Region, 2020–2027
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
The rising prevalence of diabetes entails a greater need for treatment and monitoring. In this context, multiple growth opportunities arise in the continuous glucose monitoring (CGM) solutions market. CGM devices have been extensively used for Type 1 diabetes patients. With further technological development and clinical studies, CGM’s applications expand toward Type 2 diabetes, prediabetes, weight management, nutrition tracking, and metabolic health tracking.
Most Type 1 diabetes patients—the main users of CGM—do not use these solutions due to their high costs and low reimbursements, especially in low- and middle-income countries. The adoption of these devices is very low in Asia-Pacific, Latin America, and the Middle East and Africa due to low accessibility, awareness, and affordability. A vast patient pool of diabetic and prediabetic patients needing treatment in these regions creates attractive opportunities for CGM vendors.
Vendors in the CMG solutions industry are partnering with various players across the diabetes treatment ecosystem to increase CGM adoption, data integration, and device combability. Examples of these partnerships are common between CGM vendors and insulin pen, insulin pump, and diabetes management platform providers. Technological advancements and strategic partnerships create new opportunities for CGM vendors.--BEGIN PROMO--
Research Highlights:
- Market size by revenue, covering historic and forecast data by segment (Homecare and Other Care Settings) and region (North America, Europe, Asia-Pacific, and the rest of the world)
- Market drivers and restraints
- Competitive landscape, including company market share analysis
- Market opportunity size and new business models
- Technological trends and growth opportunities for stakeholders
| Deliverable Type | Market Research |
|---|---|
| Author | Utkarsha soundankar |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | CMG solutions industry |
| Keyword 2 | Continuous Glucose Monitoring |
| Keyword 3 | blood glucose monitoring system market |
| List of Charts and Figures | CMG Solutions: Total Health Expenditure Due To Diabetes, Global, 2007–2045~ CMG Solutions: Diabetes Prevalence, 20–79 years, Global, 2007–2045~ CGM Solutions: Growth Metrics, Global, 2022~ CGM Solutions: Growth Drivers, Global, 2023–2027~ CGM Solutions: Growth Restraints, Global, 2023–2027~ CGM Solutions: Revenue Forecast, Global, 2020–2027~ CGM Solutions: Revenue Forecast by End User, Global, 2020–2027~ CGM Solutions: Revenue Forecast by Region, 2020–2027~ CGM Solutions: Revenue Share by Component, Global, 2022~ CGM Solutions: Revenue Share of Top Participants, Global, 2022~ CGM Solutions: Key Vendor Presence in CGM by Region, 2023~ CGM Solutions: Changes in Diabetes Prevalence by Region, Global, 2021 and 2045~ CGM Solutions: Target Regions for Diabetes, Global, 2021 and 2045~ CGM Solutions: Top 3 Reasons Hindering CGM Use in Tertiary Hospitals, China, 2021~ CGM Solutions: User Frequency of Use of Diabetic Devices Among Diabetic Patients, Saudi Arabia, 2020–2021~ CGM Solutions: CGM Adoption Challenges, Saudi Arabia, 2020–2021~ CGM Solutions: CGM Satisfaction Level, Saudi Arabia, 2020–2021~ CGM Solutions: Diabetes Prevalence by Type, Global, 2021~ CGM Solutions: Insulin Users, Global, 2021 and 2030~ CGM Solutions: Non-insulin Users, Global, 2021 and 2030~ CGM Solutions: Number of hospital beds, Global, 2020 and 2030~ Diabetes Devices and Services: Prediabetic Population by Region, Global, 2030~ CGM Solutions: Sports Participation, TAM and Opportunity Size, Global, 2030~ CGM Solutions: Athletes, TAM and Opportunity Size, Global, 2030~ CGM Solutions: Number of People Who Are Overweight or Obese (BMI≥25kg/m²), Global, 2020–2030~ Healthy Eating, Nutrition, and Weight Loss: Regional Share, Global, 2020~ Diabetes Devices and Services: Noninvasive Glucose Measurement, Start-ups’ Progress, Global, 2022~ Homecare Settings: Growth Metrics, Global, 2022~ Homecare Settings: Revenue Forecast, Global, 2020–2027~ Homecare Settings: Revenue Forecast by Region, 2020–2027~ Hospitals and Other Care Settings: Growth Metrics, Global, 2022~ Hospitals and Other Care Settings: Revenue Forecast, Global, 2020–2027~ Hospitals and other care settings: Revenue Forecast by Region, 2020–2027~ |
| Podcast | No |
| WIP Number | K8CB-01-00-00-00 |
Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast
Global Continuous Glucose Monitoring Solutions Market, 2027 Forecast Updated Research Available
Opportunities in Type 2 Diabetic and Non diabetic Patients Treatment Boost Future Growth Potential
RELEASE DATE
15-May-2023
15-May-2023
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: K8CB-01-00-00-00
SKU: HC03665-NA-MT_27665
$4,950.00
In stock
SKU
HC03665-NA-MT_27665